{"id":"W4327850169","doi":"10.1177/17588359231157633","title":"A rapidly evolving landscape: immune checkpoint inhibitors in pretreated metastatic endometrial cancer","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Medical Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"CancerCare Manitoba; Western University; Centre Hospitalier de l’Université de Montréal; University of Calgary; University of Manitoba; Princess Margaret Cancer Centre; University of Toronto; University of British Columbia","funders":"Merck Canada; Eisai Canada; Eisai; GlaxoSmithKline","keywords":"Medicine; Pembrolizumab; Endometrial cancer; Oncology; Internal medicine; Microsatellite instability; Lenvatinib; Metastatic breast cancer; Cancer; Breast cancer; Immunotherapy; Thyroid cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00512169,0.0003244804,0.002019626,0.00187934,0.0002290625,0.001675783,0.0005980434,0.001475408,0.003093735],"category_scores_gemma":[0.009961796,0.0002155183,0.001254697,0.003568252,0.0005637866,0.00273955,0.0006464241,0.001538997,0.0004207833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009967131,"about_ca_system_score_gemma":0.002235127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009944671,"about_ca_topic_score_gemma":0.003569807,"domain_scores_codex":[0.9983358,0.0007724533,0.0004079114,0.0001298296,0.0003084186,0.00004547708],"domain_scores_gemma":[0.9891206,0.007671073,0.00187689,0.0001130259,0.001049765,0.0001686215],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007393596,0.00005439235,0.00180334,0.1537149,0.0007210315,0.0003935801,0.0002054671,0.0005570818,0.001279653,0.00449347,0.02706341,0.8089743],"study_design_scores_gemma":[0.0009204584,0.001628237,0.01128332,0.2541184,0.004034919,0.004720486,0.001269918,0.000612686,0.0008680613,0.01063714,0.7098035,0.0001027643],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000578829,0.9944988,0.00007428168,0.004112256,0.000179506,0.00001124147,0.0000647776,0.00000319514,0.0004771422],"genre_scores_gemma":[0.006729602,0.988061,0.0003787183,0.003829476,0.0007193726,0.00003195998,0.00009624167,0.000003578278,0.0001500064],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00512169,"threshold_uncertainty_score":0.02708644,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07530303729759415,"score_gpt":0.4436830654516157,"score_spread":0.3683800281540216,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}